ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Chen, Rui; Zhang, Hao; Wu, Wantao; Li, Shuyu; Wang, Zeyu; Dai, Ziyu; Liu, Zaoqu; Zhang, Jian; Luo, Peng; Xia, Zhiwei*; Cheng, Quan*华中科技大学; 南方医科大学; 郑州大学; 1
Frontiers in Immunology2022-3-28DOI: 10.3389/fimmu.2022.833792
6被引7阅读
引用收藏
分享

摘要

Immunogenicity, influenced by tumor antigenicity and antigen presenting efficiency, critically determines the effectiveness of immune checkpoint inhibitors. The role of immunogenicity has not been fully elucidated in gliomas. In this study, a large-scale bioinformatics analysis was performed to analyze the prognostic value and predictive value of antigen presentation machinery (APM) signature in gliomas. ssGSEA algorithm was used for development of APM signature and LASSO regression analysis was used for construction of APM signature-based risk score. APM signature and risk score showed favorable performance in stratifying survival and predicting tumorigenic factors of glioma patients. APM signature and risk score were also associated with different genomic features in both training cohort TCGA and validating cohort CGGA. Furthermore, APM signature-based risk score was independently validated in three external cohorts and managed to predict immunotherapy response. A prognostic nomogram was constructed based on risk score. Risk score-derived CALR was found to mediate the invasion and polarization of macrophages based on the coculture of HMC3 and U251 cells. CALR could significantly predict immunotherapy response. In conclusion, APM signature and APM signature-based risk score could help promote the clinical management of gliomas.

学科与关键词

关键词
antigen presentation machinerygliomamicroenvironmentprognosisgenomic alterationimmunotherapy
相关
加载中…
  • Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response (vol 13, 833792, 2022)
    Chen, Rui; Zhang, Hao; Wu, Wantao; Li, Shuyu; Wang, Zeyu; Dai, Ziyu; Liu, Zaoqu; Zhang, Jian; Luo, Peng; Xia, Zhiwei*; Cheng, Quan*Frontiers in Immunology, 2022, 13: 931433.
  • Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
    Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng*Frontiers in Genetics, 2022, 13: 899125.被引 2
  • A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma
    Fan, Wenhua; Wang, Di; Li, Guanzhang; Xu, Jianbao; Ren, Changyuan; Sun, Zhiyan; Wang, Zhiliang; Ma, Wenping; Zhao, Zheng; Bao, Zhaoshi; Jiang, Tao*; Zhang, Ying*CNS Neuroscience & Therapeutics, 2022, 28(12): 2090-2103.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-03-28
卷期
第 13 卷
页码
833792
DOI
10.3389/fimmu.2022.833792
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Hunan Provincial Natural Science Foundation of China [2019JJ80056, 2020YK10]

作者

  • C

    Chen, Rui (第一作者)

    univ south china

  • Z

    Zhang, Hao

查看全部 11 位作者收起作者
  • W

    Wu, Wantao

  • L

    Li, Shuyu

    huazhong univ sci & technol

  • W

    Wang, Zeyu

  • D

    Dai, Ziyu

  • L

    Liu, Zaoqu

    1 · zhengzhou univ

  • Z

    Zhang, Jian

    southern med univ

  • L

    Luo, Peng

    southern med univ

  • X

    Xia, Zhiwei (通讯)

  • C

    Cheng, Quan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417